Debut Plus

3,125.6

+38.28 +1.24%

17 Jul 2026

NSE Listed

ASM 1

NGL Fine Chem Limited (NGLFINE)

Volume: 2,981Avg Vol 1W: 4,123.8Avg Vol 1M: 11,708.252W Range:1,175.53,329
Key Ratios
Checked 6h ago
Market Cap₹1,953 Cr
Current Price₹3,125.6
Previous Close₹3,087.32
High / Low (52w)₹3,329 / ₹1,175.5
Volume2,981
Avg Vol (1W)4,123.8
Avg Vol (1M)11,708.2
Stock P/E37.97
Book Value₹452.6
Dividend Yield
ROE6.7%
ROA
Revenue (TTM)₹377 Cr
Revenue Growth
Profit Margin
Total Debt₹25 Cr
Shares Outstanding
Face Value₹5
EPS (TTM)₹29.35
P/B2.46
Debt / Equity0.2
50 DMA₹2,903.78
200 DMA₹2,077.46
Day change+1.24%
SurveillanceASM 1 (as of 2026-07-14)
Price Chart
3,125.6 123.18% · 1Y
323712051.0L
2025-07-17
2026-07-16

20-day avg volume: 12K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 42% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹91 Cr₹93 Cr₹89 Cr₹95 Cr₹104 Cr₹120 Cr₹128 Cr₹149 Cr
EBITDA₹12 Cr₹14 Cr₹2 Cr₹2 Cr₹13 Cr₹14 Cr₹22 Cr₹19 Cr
Net Profit₹9 Cr₹10 Cr₹1 Cr₹1 Cr₹9 Cr₹10 Cr₹16 Cr₹13 Cr
EPS
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹157 Cr₹155 Cr₹266 Cr₹328 Cr₹284 Cr₹353 Cr₹377 Cr
EBITDA₹30 Cr₹14 Cr₹79 Cr₹68 Cr₹29 Cr₹56 Cr₹30 Cr
Net Profit₹20 Cr₹8 Cr₹57 Cr₹50 Cr₹20 Cr₹41 Cr₹21 Cr
EPS32.5813.4991.8180.7733.1866.8834.19
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹142 Cr₹154 Cr₹207 Cr₹277 Cr₹287 Cr₹356 Cr₹433 Cr
Total Liabilities₹50 Cr₹55 Cr₹53 Cr₹74 Cr₹65 Cr₹93 Cr₹151 Cr
Equity₹92 Cr₹99 Cr₹154 Cr₹203 Cr₹223 Cr₹263 Cr₹282 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹16 Cr₹24 Cr₹48 Cr₹31 Cr₹42 Cr₹34 Cr₹42 Cr
Investing₹-10 Cr₹-20 Cr₹-25 Cr₹-14 Cr₹-27 Cr₹-27 Cr₹-35 Cr
Financing₹0 Cr₹-1 Cr₹-1 Cr₹-1 Cr₹-1 Cr₹-1 Cr₹-1 Cr
Free Cash Flow₹16 Cr₹24 Cr₹48 Cr₹31 Cr₹42 Cr₹34 Cr₹42 Cr
Efficiency & Working Capital
ROCE15.4%
Interest Coverage9.5
Dividend Payout
Debtor Days81 d
Inventory Days51 d
Payable Days57 d
Cash Conversion Cycle75 d
Working Capital Days132 d
Shareholding Details

As of 2026-03-31

Promoter72.7%
FII0%
DII0%
Institutions0%
Public27.2%
Promoter Pledge0%
No. of Shareholders12,516
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters73.5%73.1%73.1%72.7%72.7%72.7%72.7%72.7%72.7%72.7%72.7%72.7%
FIIs0%0%0%0.1%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public26.5%26.9%26.9%27.2%27.2%27.2%27.2%27.3%27.3%27.3%27.3%27.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders17,06617,62316,41015,04114,60814,57514,11014,38614,01013,38712,83412,516
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Rajesh Narayan LawandeShareholding of Promoter and Promoter Group21.9%13,52,366
Rahul Jayant NachaneShareholding of Promoter and Promoter Group17.5%10,83,450
Sunita Sandeep PotdarShareholding of Promoter and Promoter Group13.4%8,26,510
Ajita Rahul NachaneShareholding of Promoter and Promoter Group11.6%7,13,449
Pci Ferrmone Chemicals India Private LimitedShareholding of Promoter and Promoter Group8.4%5,17,871
Pushpa Narayan LawandeShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Rahul Jayant Nachane00%2026-03-31
Rajesh Narayan Lawande00%2026-03-31
Pushpa Narayan Lawande00%2026-03-31
Ajita Rahul Nachane00%2026-03-31
Sunita Sandeep Potdar00%2026-03-31
Pci Ferrmone Chemicals India Private Limited00%2026-03-31
Rahul Nachane00%2025-12-31
Rajesh Lawande00%2025-12-31
Ajita Nachane00%2025-12-31
Pushpa Lawande00%2025-12-31
Sunita Potdar00%2025-12-31
Pci Ferrmone Chemicals (india) Pvt Ltd00%2025-12-31
Board of Directors
NameDesignationYear
Dhananjay N MungaleChairman & Independent Directo2025
Rahul J NachaneED / MD / Promoter2025
Rajesh N LawandeED / WTD / CFO / Promoter2025
Jayaram SitaramIndependent Non Exe. Director2025
Ajita NachaneIndependent Non Exe. Director2025
Sarala MenonIndependent Non Exe. Director2025
S R DeoIndependent Non Exe. Director2025
Shivam GharatCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹5533
Corporate Actions
TypeDateValueRemark
dividend2025-08-12₹1.75 (35%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202545106052
202512000013
202529105035
Insider / Designated-Person Trades

26 recent disclosure(s)

SUNITA POTDARDisposal · 1,069
SUNITA POTDARDisposal · 368
SUNITA POTDARDisposal · 1,281
SUNITA POTDARDisposal · 1,190
SUNITA POTDARDisposal · 282
SUNITA POTDARDisposal · 1,364
Substantial Acquisitions (SAST)

8 disclosure(s)

Market19/02/2024 · 20,000
Market15/09/2023 · 636
Market13/09/2023 · 474
Market12/09/2023 · 10
Market11/09/2023 · 4,191
Market08/09/2023 · 4,823
Company Information
Incorporated1981
ChairmanDhananjay N Mungale
AuditorManek & Associates
Investor Email[email protected]
🌐 www.nglfinechem.com

📍 301 E Square Subhash Road, Vile Parle (East), Mumbai, Maharashtra, 400057

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search